These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19320233)

  • 1. On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future.
    Liaw YF
    Antivir Ther; 2009; 14(1):13-22. PubMed ID: 19320233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Buster EH; Schalm SW; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon-based versus direct antiviral therapy in patients with chronic hepatitis B].
    Tornai I
    Orv Hetil; 2011 May; 152(22):869-74. PubMed ID: 21565754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
    Colle I; Adler M; Brenard R; Henrion J; Langlet P; Michielsen P; Orlent H; Reynaert H; Sprengers D; Stärkel P; Van Damme P; Verslype C; Delwaide J;
    Acta Gastroenterol Belg; 2007; 70(4):389-420. PubMed ID: 18330099
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological agents for the treatment of chronic hepatitis B].
    Sánchez-Tapias JM
    Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of antiviral-resistant chronic hepatitis B virus infection].
    Yim HJ
    Korean J Gastroenterol; 2008 Jun; 51(6):346-59. PubMed ID: 18604136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
    Nguyen MH; Keeffe EB
    J Viral Hepat; 2009 Mar; 16(3):149-55. PubMed ID: 19236641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: current antiviral therapy of chronic hepatitis B.
    Ayoub WS; Keeffe EB
    Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of chronic hepatitis B].
    von Weizsäcker F
    Praxis (Bern 1994); 2005 Apr; 94(16):649-52. PubMed ID: 15900829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.
    Yu S; Zhou Q; Zhao XM; Yuan M; Wang CT; Cheng XG; Zhang ZH; Li X
    Saudi J Gastroenterol; 2014; 20(6):350-5. PubMed ID: 25434315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
    Chien RN
    J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
    Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
    Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
    Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
    J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic perspectives in HBV: when to stop NAs.
    Pérez-Cameo C; Pons M; Esteban R
    Liver Int; 2014 Feb; 34 Suppl 1():146-53. PubMed ID: 24373092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of hepatitis B virus infection].
    Trautwein C
    Praxis (Bern 1994); 2006 Sep; 95(36):1389-97. PubMed ID: 16989182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues.
    Leung N
    Liver Int; 2011 Jan; 31 Suppl 1():85-9. PubMed ID: 21205143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
    Salpini R; Alteri C; Cento V; Pollicita M; Micheli V; Gubertini G; De Sanctis GM; Visca M; Romano S; Sarrecchia C; Andreoni M; Angelico M; Parruti G; Svicher V; Perno CF
    J Med Virol; 2013 Jun; 85(6):996-1004. PubMed ID: 23588725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
    Yang HJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    J Med Virol; 2012 Mar; 84(3):424-30. PubMed ID: 22246827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.